| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |